Human Immunodeficiency Virus Type 1 Latency Model for High-Throughput Screening

Human immunodeficiency virus type 1 (HIV-1) is not eliminated from patients even after years of antiretroviral therapy, apparently due to the presence of latently infected cells. Here we describe the development of a cell-based system of latency that can be used for high-throughput screening aimed a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Micheva-Viteva, Sofiya, Pacchia, Annmarie L., Ron, Yacov, Peltz, Stuart W., Dougherty, Joseph P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1315948/
https://ncbi.nlm.nih.gov/pubmed/16304201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.12.5185-5188.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados